Bernhardt G Zeiher insider trades

Open-market stock purchases and sales by Bernhardt G Zeiher, Director at Entrada Therapeutics, Inc, from SEC Form 4 filings since Apr 4, 2023.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -21%.

Recent trades

DateStockTradeValue
Jun 10, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Jun 4, 2026AMLX Amylyx Pharmaceuticals, IncBought (not open market)—
May 20, 2026TRDA Entrada Therapeutics, IncBought$29.3K
Jan 26, 2026ABEO Abeona Therapeutics IncBought (not open market)—

Companies traded

  • TRDA Entrada Therapeutics, Inc: 1 buy, last Jun 10, 2026
  • AMLX Amylyx Pharmaceuticals, Inc: 1 buy, last Jun 4, 2026
  • ABEO Abeona Therapeutics Inc: other filings, last Jan 26, 2026

Get free alerts when Bernhardt G Zeiher files a new trade →